Telemedicine consultations are being highly publicized for the management of dry eye disease amidst the coronavirus (COVID-19) pandemic. Clinicians are resorting to Zoom videoconference, since patients are creating a demand for remote healthcare services. Thus, telemedicine holds promising potentials in revenue generation activities for companies in the dry eye disease treatment market.
More number of patients have been appreciative about telehealth services. This has helped to increase the uptake of anti-inflammatory and artificial tears products. However, clinicians are coming across compliance issues in patients such as erratic consumption of their omega-3 fatty acid supplements. Hence, doctors are holding positive hopes for the pandemic to subside soon so that they can provide written prescriptions and special instructions to patients for effective management of DED. This is likely to drive the dry eye disease treatment market.
Although anti-inflammatory and artificial tears products hold a major share of the revenue in the dry eye disease treatment market, manufacturers are innovating in state-of-the-art devices to improve patient outcomes. For instance, Device Technologies AU-a medical devices supplier to Australia and New Zealand, is strengthening its distribution channels for medical equipment manufacturer Quantel Medical’s device LacryStim IPL that helps in treating DED. As such, device manufacturers in the dry eye disease treatment market are gaining proficiency in intense pulsed light technology, which is intended to treat dry eye diseases such as meibomian gland dysfunction. Thus, technological innovations contribute a modest share to the market, which is predicted to expand at a CAGR of ~4% during the forecast period.
Device manufacturers are aiming to acquire European regulatory clearance for the intense pulsed light technology that is instrumental in reducing inflammation in DED patients.
Innovative contact lens hold promising potentials for dry eye disease treatment. For instance, Swanson School of Engineering graduate student researcher Alexis Nolfi who is suffering from the disease from the past several years, has introduced CyteSolutions Lens that target inflammatory dry eye pathways. Researchers in the dry eye disease treatment market are collaborating with eye doctors to innovate in contact lenses that are capable of replacing artificial tears products. Such breakthrough innovations are bolstering the growth for the dry eye disease treatment market, which is estimated to cross the value of US$ 8.7 Bn by the end of 2030.
Inadequate relief from artificial tears products are posing as a challenge for companies in the market for dry eye disease treatment. Hence, companies in the market for dry eye disease should collaborate with researchers and innovators to design contact lenses that help in the management of inflammatory dry eye pathways.
The growing awareness about multistage management algorithm for dry eye disease is acquiring increased credibility, owing to its evidence-based and personalized approach. Healthcare companies in the dry eye disease treatment market are increasing their R&D muscle to develop products that restore the homeostasis of the ocular surface and tear film of the eyes. The Tear Film and Ocular Surface Society (TFOS) is working relentlessly to create awareness about multistage management algorithms for the management of dry eye disease.
Healthcare companies in the dry eye disease treatment market are increasing efforts to educate patients about the negative ramifications of dry eye disease, which is emerging as a key solution to prevent its progression. Manufacturers are increasing their production capabilities to develop fatty acid oral supplements that help to improve overall patient comfort.
Analysts’ Viewpoint
Binge watching streaming TV and spending extensive hours with devices have bolstered the uptake of DED products amidst the COVID-19 outbreak. Manufacturers are increasing their focus in devices with the intense pulsed light technology that is expecting high demand in Europe, whilst the revenue of the dry eye disease treatment market in the region is projected for aggressive growth.
The revenue of anti-inflammatory products is anticipated to take a leap from 42% in 2019 and reach 50% by 2030 during the forecast period. However, clinical evidence of the LASIK (laser in-situ keratomileusis) surgery being ineffective in patients is likely to impede market growth. Hence, companies should innovate in contact lenses that help in treating inflammatory dry eye diseases.
Dry eye disease treatment market to reach valuation of US$ 8.7 Bn by 2030
Dry eye disease treatment market is projected to expand at a CAGR of ~4% from 2020 to 2030
Dry eye disease treatment market is driven by rise in incidence of dry eye disease and increase in R&D activities
The anti-inflammatory segment is anticipated to account for major share of the global dry eye disease treatment market
Key players in the global dry eye disease treatment market include Novartis AG, Allergan, Bausch Health Companies, Inc., Santen Pharmaceutical Co., Ltd., OASIS Medical
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Dry Eye Disease Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Dry Eye Disease Treatment Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
5. Key Insights
5.1. Global Dry Eye Disease Treatment Market: Key Mergers & Acquisitions
5.2. Pipeline Analysis
5.3. Disease Prevalence & Incidence Rate Globally with Key Countries
5.4. Technological Advancement
5.5. COVID-19 Pandemics Impact on Industry (Short / Mid / Long Term Impact)
6. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Product
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Dry Eye Disease Treatment Market Value Forecast, by Product, 2018–2030
6.2.1. Artificial Tears
6.2.2. Anti-inflammatory
6.2.2.1. Cyclosporine
6.2.2.2. Corticosteroid
6.2.2.3. Others
6.2.3. Punctal Plugs
6.2.4. Secretagogue
6.2.5. Others
6.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product
7. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Disease
7.1. Introduction & Definition
7.1.1. Key Findings / Developments
7.2. Global Dry Eye Disease Treatment Market Value Forecast, by Disease, 2018–2030
7.2.1. Evaporative Dry Eye Syndrome
7.2.2. Aqueous Dry Eye Syndrome
7.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease
8. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.1.1. Key Findings / Developments
8.2. Global Dry Eye Disease Treatment Market Value Forecast, by Distribution Channel, 2018–2030
8.2.1. Hospital Pharmacies
8.2.2. Retail Pharmacies
8.2.3. Online Pharmacies
8.3. Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel
9. Global Dry Eye Disease Treatment Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Dry Eye Disease Treatment Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Region
10. North America Dry Eye Disease Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
10.2.1. Artificial Tears
10.2.2. Anti-inflammatory
10.2.2.1. Cyclosporine
10.2.2.2. Corticosteroid
10.2.2.3. Others
10.2.3. Punctal Plugs
10.2.4. Secretagogue
10.2.5. Others
10.3. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
10.3.1. Evaporative Dry Eye Syndrome
10.3.2. Aqueous Dry Eye Syndrome
10.4. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
10.5.1. U.S.
10.5.2. Canada
10.6. North America Dry Eye Disease Treatment Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Disease
10.6.3. By Distribution Channel
10.6.4. By Country
11. Europe Dry Eye Disease Treatment Market Analysis and Forecast
11.1. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
11.1.1. Artificial Tears
11.1.2. Anti-inflammatory
11.1.2.1. Cyclosporine
11.1.2.2. Corticosteroid
11.1.2.3. Others
11.1.3. Punctal Plugs
11.1.4. Secretagogue
11.1.5. Others
11.2. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
11.2.1. Evaporative Dry Eye Syndrome
11.2.2. Aqueous Dry Eye Syndrome
11.3. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
11.3.1. Hospital Pharmacies
11.3.2. Retail Pharmacies
11.3.3. Online Pharmacies
11.4. Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
11.4.1. Germany
11.4.2. U.K.
11.4.3. France
11.4.4. Spain
11.4.5. Italy
11.4.6. Rest of Europe
11.5. Europe Dry Eye Disease Treatment Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By Disease
11.5.3. By Distribution Channel
11.5.4. By Country/Sub-region
12. Asia Pacific Dry Eye Disease Treatment Market Analysis and Forecast
12.1. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
12.1.1. Artificial Tears
12.1.2. Anti-inflammatory
12.1.2.1. Cyclosporine
12.1.2.2. Corticosteroid
12.1.2.3. Others
12.1.3. Punctal Plugs
12.1.4. Secretagogue
12.1.5. Others
12.2. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
12.2.1. Evaporative Dry Eye Syndrome
12.2.2. Aqueous Dry Eye Syndrome
12.3. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
12.3.1. Hospital Pharmacies
12.3.2. Retail Pharmacies
12.3.3. Online Pharmacies
12.4. Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
12.4.1. China
12.4.2. Japan
12.4.3. India
12.4.4. Australia & New Zealand
12.4.5. Rest of Asia Pacific
12.5. Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By Disease
12.5.3. By Distribution Channel
12.5.4. By Country/Sub-region
13. Latin America Dry Eye Disease Treatment Market Analysis and Forecast
13.1. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
13.1.1. Artificial Tears
13.1.2. Anti-inflammatory
13.1.2.1. Cyclosporine
13.1.2.2. Corticosteroid
13.1.2.3. Others
13.1.3. Punctal Plugs
13.1.4. Secretagogue
13.1.5. Others
13.2. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
13.2.1. Evaporative Dry Eye Syndrome
13.2.2. Aqueous Dry Eye Syndrome
13.3. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
13.3.1. Hospital Pharmacies
13.3.2. Retail Pharmacies
13.3.3. Online Pharmacies
13.4. Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
13.4.1. Brazil
13.4.2. Mexico
13.4.3. Rest of Latin America Latin America
13.5. Latin America Dry Eye Disease Treatment Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By Disease
13.5.3. By Distribution Channel
13.5.4. By Country/Sub-region
14. Middle East & Africa Dry Eye Disease Treatment Market Analysis and Forecast
14.1.1.
14.2. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
14.2.1. Artificial Tears
14.2.2. Anti-inflammatory
14.2.2.1. Cyclosporine
14.2.2.2. Corticosteroid
14.2.2.3. Others
14.2.3. Punctal Plugs
14.2.4. Secretagogue
14.2.5. Others
14.3. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
14.3.1. Evaporative Dry Eye Syndrome
14.3.2. Aqueous Dry Eye Syndrome
14.4. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Disease
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region
15. Competitive Landscape
15.1. Market Player - Competition Matrix (by Tier and Size of companies)
15.2. Market Share / Position Analysis, by Company, 2018
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Novartis AG
15.4.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.1.2. Growth Strategies
15.4.1.3. SWOT Analysis
15.4.2. Allergan
15.4.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.2.2. Growth Strategies
15.4.2.3. SWOT Analysis
15.4.3. Santen Pharmaceutical Co., Ltd.
15.4.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.3.2. Growth Strategies
15.4.3.3. SWOT Analysis
15.4.4. OASIS Medical
15.4.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.4.2. Growth Strategies
15.4.4.3. SWOT Analysis
15.4.5. Sun Pharmaceutical Industries Ltd.
15.4.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.5.2. Growth Strategies
15.4.5.3. SWOT Analysis
15.4.6. Johnson & Johnson
15.4.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.6.2. Growth Strategies
15.4.6.3. SWOT Analysis
15.4.7. Otsuka Pharmaceutical Co., Ltd.
15.4.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.7.2. Growth Strategies
15.4.7.3. SWOT Analysis
15.4.8. Sentiss Pharma Pvt. Ltd.
15.4.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.8.2. Growth Strategies
15.4.8.3. SWOT Analysis
15.4.9. RegeneRx (ReGenTree, LLC)
15.4.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.9.2. Growth Strategies
15.4.9.3. SWOT Analysis
15.4.10. Bausch Health Companies, Inc.
15.4.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.4.10.2. Growth Strategies
15.4.10.3. SWOT Analysis
List of Tables
Table 1: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 2: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 3: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 4: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 5: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 6: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 7: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 8: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 9: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 10: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 11: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 12: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 13: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 14: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 15: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 16: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 17: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 18: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 19: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 20: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 21: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 22: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 23: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 24: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 25: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
Table 26: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2018–2030
Table 27: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Product, 2018–2030
Table 28: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Anti-inflammatory, 2018–2030
Table 29: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Disease, 2018–2030
Table 30: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, by Distribution Channel, 2018–2030
List of Figures
Figure 01: Global Dry Eye Disease Treatment Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2030
Figure 02: Global Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 03: Global Dry Eye Disease Treatment Market Value Share (%), by Product, 2019
Figure 04: Global Dry Eye Disease Treatment Market Value Share (%), by Disease, 2019
Figure 05: Global Dry Eye Disease Treatment Market Value Share (%), by Distribution Channel, 2019
Figure 06: Global Dry Eye Disease Treatment Market Value Share (%), by Region, 2019
Figure 07: Global Dry Eye Disease Treatment Market Value Share Analysis (%), by Product, 2019 and 2030
Figure 08: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 09: Global Dry Eye Disease Treatment Market Value Share (%), by Anti-inflammatory, 2019 and 2030
Figure 10: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Artificial Tears, 2018–2030
Figure 11: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anti-inflammatory, 2018–2030
Figure 12: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Secretagogue, 2018–2030
Figure 13: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Punctal Plugs, 2018–2030
Figure 14: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2030
Figure 15: Global Dry Eye Disease Treatment Market Value Share (%) Analysis, by Disease, 2019 and 2030
Figure 16: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 17: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Evaporative Dry Eye Syndrome, 2018–2030
Figure 18: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aqueous Dry Eye Syndrome, 2018–2030
Figure 19: Global Dry Eye Disease Treatment Market Value Share (%)Analysis, by Distribution Channel, 2019 and 2030
Figure 20: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 21: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacies, 2018–2030
Figure 22: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacies, 2018–2030
Figure 23: Global Dry Eye Disease Treatment Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacies, 2018–2030
Figure 24: Global Dry Eye Disease Treatment Market Value Share Analysis, by Region, 2019 and 2030
Figure 25: Global Dry Eye Disease Treatment Market Attractiveness Analysis, by Region, 2020–2030
Figure 26: North America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 27: North America Dry Eye Disease Treatment Market Value Share Analysis, by Country, 2019 and 2027
Figure 28: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country, 2020–2030
Figure 29: North America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
Figure 30: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 31: North America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
Figure 32: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 33: North America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 34: North America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 35: Europe Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 36: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2030
Figure 37: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 38: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
Figure 39: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 40: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
Figure 41: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 42: Europe Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 43: Europe Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 44: Asia Pacific Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 45: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 46: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 47: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
Figure 48: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 49: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
Figure 50: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 51: Asia Pacific Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 52: Asia Pacific Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 53: Latin America Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 54: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 55: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 56: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
Figure 57: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 58: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
Figure 59: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 60: Latin America Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 61: Latin America Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Figure 62: Middle East & Africa Dry Eye Disease Treatment Market Value (US$ Mn) Forecast, 2018–2030
Figure 63: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Country/Sub-region, 2019 and 2027
Figure 64: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 65: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Product, 2019 and 2030
Figure 66: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Product, 2020–2030
Figure 67: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Disease, 2019 and 2030
Figure 68: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Disease, 2020–2030
Figure 69: Middle East & Africa Dry Eye Disease Treatment Market Value Share Analysis, by Distribution Channel, 2019 and 2030
Figure 70: Middle East & Africa Dry Eye Disease Treatment Market Attractiveness Analysis, by Distribution Channel, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Dry Eye Disease Treatment Market
